Usefulness of Antibodies to Oxidized Low-Density Lipoproteins as Predictors of Morbidity and Prognosis in Heart Failure Patients Aged ≥65 Years
Elevated level of antibodies to oxidized low-density lipoproteins (OxLDL-Ab) was shown to reliably predict morbidity and mortality in patients with heart failure (HF). Two hundred and eleven patients aged ≥65 years treated at the Heart Failure Unit, Tel Aviv-Sourasky Medical Center, were included in...
Saved in:
Published in | The American journal of cardiology Vol. 116; no. 9; pp. 1379 - 1384 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.11.2015
Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Elevated level of antibodies to oxidized low-density lipoproteins (OxLDL-Ab) was shown to reliably predict morbidity and mortality in patients with heart failure (HF). Two hundred and eleven patients aged ≥65 years treated at the Heart Failure Unit, Tel Aviv-Sourasky Medical Center, were included in this retrospective study. The end points were time to the first hospitalization (morbidity), all-cause mortality, and a combination of the two (composite outcome). HF duration ranged from 8 to 10.5 years. Mean follow-up was 5.2 ± 1.9 years. The mean number of clinical visits was 18.3 ± 2.4. Participants were divided according to OxLDL-Ab level. Group 1 had Ox LDL-Ab level <200 arbitrary U/ml. Group 2 had OxLDL-Ab level ≥200 arbitrary U/ml. The mean time to the first hospitalization was 25.8 ± 17.0 months. The mortality rate was 44.1%. Combined mortality and hospitalization rate was 58.8%. Adjusted hazard ratios of OxLDL-Ab for hospitalization were 3.16, p <0.001, 95% confidence interval 1.740 to 5.736 and for composite outcome 2.67, p <0.001, 95% confidence interval 1.580 to 4.518. In conclusion, OxLDL-Ab level was the best predictor for both hospitalization and composite outcome. It may, thus, serve as a useful clue for early and more accurate detection of poorly controlled HF and as a marker for imminent exacerbations of thereof. |
---|---|
AbstractList | Elevated level of antibodies to oxidized low-density lipoproteins (OxLDL-Ab) was shown to reliably predict morbidity and mortality in patients with heart failure (HF). Two hundred and eleven patients aged ≥65 years treated at the Heart Failure Unit, Tel Aviv-Sourasky Medical Center, were included in this retrospective study. The end points were time to the first hospitalization (morbidity), all-cause mortality, and a combination of the two (composite outcome). HF duration ranged from 8 to 10.5 years. Mean follow-up was 5.2 ± 1.9 years. The mean number of clinical visits was 18.3 ± 2.4. Participants were divided according to OxLDL-Ab level. Group 1 had Ox LDL-Ab level <200 arbitrary U/ml. Group 2 had OxLDL-Ab level ≥200 arbitrary U/ml. The mean time to the first hospitalization was 25.8 ± 17.0 months. The mortality rate was 44.1%. Combined mortality and hospitalization rate was 58.8%. Adjusted hazard ratios of OxLDL-Ab for hospitalization were 3.16, p <0.001, 95% confidence interval 1.740 to 5.736 and for composite outcome 2.67, p <0.001, 95% confidence interval 1.580 to 4.518. In conclusion, OxLDL-Ab level was the best predictor for both hospitalization and composite outcome. It may, thus, serve as a useful clue for early and more accurate detection of poorly controlled HF and as a marker for imminent exacerbations of thereof. Elevated level of antibodies to oxidized low-density lipoproteins (OxLDL-Ab) was shown to reliably predict morbidity and mortality in patients with heart failure (HF). Two hundred and eleven patients aged ≥65 years treated at the Heart Failure Unit, Tel Aviv-Sourasky Medical Center, were included in this retrospective study. The end points were time to the first hospitalization (morbidity), all-cause mortality, and a combination of the two (composite outcome). HF duration ranged from 8 to 10.5 years. Mean follow-up was 5.2 ± 1.9 years. The mean number of clinical visits was 18.3 ± 2.4. Participants were divided according to OxLDL-Ab level. Group 1 had Ox LDL-Ab level <200 arbitrary U/ml. Group 2 had OxLDL-Ab level ≥200 arbitrary U/ml. The mean time to the first hospitalization was 25.8 ± 17.0 months. The mortality rate was 44.1%. Combined mortality and hospitalization rate was 58.8%. Adjusted hazard ratios of OxLDL-Ab for hospitalization were 3.16, p <0.001, 95% confidence interval 1.740 to 5.736 and for composite outcome 2.67, p <0.001, 95% confidence interval 1.580 to 4.518. In conclusion, OxLDL-Ab level was the best predictor for both hospitalization and composite outcome. It may, thus, serve as a useful clue for early and more accurate detection of poorly controlled HF and as a marker for imminent exacerbations of thereof. Elevated level of antibodies to oxidized low-density lipoproteins (OxLDL-Ab) was shown to reliably predict morbidity and mortality in patients with heart failure (HF). Two hundred and eleven patients aged >=65 years treated at the Heart Failure Unit, Tel Aviv-Sourasky Medical Center, were included in this retrospective study. The end points were time to the first hospitalization (morbidity), all-cause mortality, and a combination of the two (composite outcome). HF duration ranged from 8 to 10.5 years. Mean follow-up was 5.2 ± 1.9 years. The mean number of clinical visits was 18.3 ± 2.4. Participants were divided according to OxLDL-Ab level. Group 1 had Ox LDL-Ab level <200 arbitrary U/ml. Group 2 had OxLDL-Ab level >=200 arbitrary U/ml. The mean time to the first hospitalization was 25.8 ± 17.0 months. The mortality rate was 44.1%. Combined mortality and hospitalization rate was 58.8%. Adjusted hazard ratios of OxLDL-Ab for hospitalization were 3.16, p <0.001, 95% confidence interval 1.740 to 5.736 and for composite outcome 2.67, p <0.001, 95% confidence interval 1.580 to 4.518. In conclusion, OxLDL-Ab level was the best predictor for both hospitalization and composite outcome. It may, thus, serve as a useful clue for early and more accurate detection of poorly controlled HF and as a marker for imminent exacerbations of thereof. |
Author | Michowitz, Yoav, MD Rogowski, Ori, MD George, Jacob, MD Charach, Gideon, MD Grosskopf, Itamar, MD Charach, Lior, BA Argov, Ori, MD |
Author_xml | – sequence: 1 fullname: Charach, Gideon, MD – sequence: 2 fullname: Michowitz, Yoav, MD – sequence: 3 fullname: Rogowski, Ori, MD – sequence: 4 fullname: Charach, Lior, BA – sequence: 5 fullname: Argov, Ori, MD – sequence: 6 fullname: George, Jacob, MD – sequence: 7 fullname: Grosskopf, Itamar, MD |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26372212$$D View this record in MEDLINE/PubMed |
BookMark | eNqFksFu1DAQhi1URLeFRwBZ4sIlwXZiO7mAVoVSpEWtBD1wshxnUnnJ2lvbAZY34MoTcOFFeBSeBG93AakXJEuW7W_-8cw_R-jAeQcIPaSkpISKp8tSr5ZGh75khPKSyJLw6g6a0Ua2BW1pdYBmhBBWtLRuD9FRjMt8pJSLe-iQiUoyRtkMfbuMMEyjgxixH_DcJdv53kLEyePzz7a3X6DHC_-peAEu2rTBC7v26-ATWBexjvgiQG9N8uFG4I0PXQ7KnHZ9fvNXzkcbsXX4DHRI-FTbcQqAL3Sy4FLE86uc4NfXH4L__P4-I_E-ujvoMcKD_X6MLk9fvjs5Kxbnr16fzBeFqesmFZqTgXLTNxUB2nYtpUQ3AFLnq36opRBdy2sGuuIdiKYWjeAmLyIHwSWD6hg92enmaq4niEmtbDQwjtqBn6KiuUUta1hTZ_TxLXTpp-Dy726oWraybjLFd5QJPsYAg1oHu9JhoyhRW9PUUu1NU1vTFJEqm5bjHu3Vp24F_d-oPy5l4PkOgNyOjxaCiiY3z-TGBzBJ9d7-N8WzWwpmtM4aPX6ADcR_1ajIFFFvt5OzHRzKCZVcyOo3D4XDxg |
CODEN | AJCDAG |
CitedBy_id | crossref_primary_10_1111_ene_13943 crossref_primary_10_1186_s12944_016_0360_y crossref_primary_10_47224_revistamaster_v8i15_359 crossref_primary_10_1016_j_atherosclerosis_2020_02_003 crossref_primary_10_1212_WNL_0000000000006118 |
Cites_doi | 10.1152/ajpheart.00734.2013 10.1016/j.ijcard.2014.11.018 10.1016/j.cardfail.2009.05.009 10.1161/01.CIR.98.15.1487 10.1016/0140-6736(92)90926-T 10.1016/j.mam.2004.02.003 10.1161/01.ATV.19.1.23 10.1007/s11883-012-0266-8 10.1016/j.jacc.2003.05.011 10.1161/01.CIR.0000093661.90582.c4 10.1161/01.CIR.91.1.10 10.1159/000357835 10.1016/j.ijcard.2004.10.024 10.1161/01.ATV.21.5.844 10.1126/science.877547 10.1016/S0735-1097(02)01721-7 10.1093/eurheartj/14.11.1493 10.1111/j.1749-6632.2001.tb03943.x 10.1016/S0165-2478(99)00050-4 10.1161/01.CIR.0000054164.99881.00 10.1161/01.CIR.97.16.1536 10.1038/sj.ejcn.1601476 10.1073/pnas.192399699 10.1016/j.ejheart.2005.04.015 10.1016/S0735-1097(00)00916-5 10.1016/0891-5849(93)90145-K |
ContentType | Journal Article |
Copyright | Elsevier Inc. 2015 Elsevier Inc. Copyright © 2015 Elsevier Inc. All rights reserved. Copyright Elsevier Limited Nov 1, 2015 |
Copyright_xml | – notice: Elsevier Inc. – notice: 2015 Elsevier Inc. – notice: Copyright © 2015 Elsevier Inc. All rights reserved. – notice: Copyright Elsevier Limited Nov 1, 2015 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7RV 7TS 7X7 7XB 88E 8FD 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ GUQSH K9. KB0 M0S M1P M2O M7Z MBDVC NAPCQ P64 PQEST PQQKQ PQUKI Q9U 7X8 |
DOI | 10.1016/j.amjcard.2015.07.053 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) ProQuest Nursing & Allied Health Database Physical Education Index ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials AUTh Library subscriptions: ProQuest Central ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) Medical Database ProQuest research library Biochemistry Abstracts 1 Research Library (Corporate) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Research Library Prep ProQuest Central Student Technology Research Database ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College Research Library (Alumni Edition) Physical Education Index ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Research Library ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Biochemistry Abstracts 1 ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Research Library Prep MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1879-1913 |
EndPage | 1384 |
ExternalDocumentID | 3838334091 10_1016_j_amjcard_2015_07_053 26372212 S0002914915017567 1_s2_0_S0002914915017567 |
Genre | Journal Article |
GeographicLocations | Israel Tel Aviv Israel |
GeographicLocations_xml | – name: Israel – name: Tel Aviv Israel |
GroupedDBID | - 08R 0R 1 1- 123 1B1 1P 1RT 1~. 1~5 23M 3O- 3V. 4.4 457 4G. 53G 55 5RE 5VS 6J9 7-5 71M 7RV 7X7 88E 8FI 8FJ 8G5 8P 9JM AABNK AACTN AAEDT AAIAV AAIKJ AAKOC AALMO AALRI AAQFI AAQQT AAQXK AAWTL AAXUO AAYOK ABBQC ABFLS ABFNM ABLJU ABLVK ABMAC ABMZM ABOCM ABPIF ABPPZ ABPTK ABUWG ABWYI ABXDB ABYKQ ACDAQ ACGFO ACGFS ACIUM ACIWK ACPRK ACRLP ADALY ADBBV ADEZE ADFRT AEBSH AEKER AENEX AEVXI AFFNX AFKRA AFKWA AFRAH AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AHMBA AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AZFZN AZQEC BBAFP BENPR BKEYQ BKOJK BKOMP BLXMC BNPGV BPHCQ BVXVI CS3 DWQXO EBS EFJIC EJD EMOBN EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FO FYUFA G- G-2 G-Q GBLVA GJ GNUQQ GUQSH HEB HMK HMO HVGLF HZ IH2 IHE IPNFZ J1W J5H K K-O KOM L7B LCYCR M M1P M29 M2O M41 MO0 N9A NAPCQ O-L O9- OA. OAUVE OHT OL OVD OZT P-8 P-9 P2P PADUT PC. PQEST PQQKQ PQUKI PRINS PROAC PSQYO Q38 R2- RIG ROL RPZ SAE SDF SDG SEL SES SJN SPCBC SSH SSZ SV3 T5K TEORI TWZ UNMZH UV1 WH7 WOW WUQ X7M XPP YFH YOC YQJ YZZ Z5R ZA5 ZGI ZXP --- --K --M .1- .FO .~1 0R~ 1P~ 8P~ AAEDW ABJNI AXJTR CCPQU EFLBG FYGXN HMCUK OL~ UKHRP ~G- AAXKI ADUKH AFCTW AKRWK ALIPV CGR CUY CVF ECM EIF NPM .55 .GJ 1CY AAYXX ADMUD AFJKZ CITATION HZ~ YYP 7TS 7XB 8FD 8FK FR3 K9. M7Z MBDVC P64 Q9U 7X8 |
ID | FETCH-LOGICAL-c448t-a50f15cd830e19b9110a8ee7acd8df4766b9542ea35be6846865c65c07f6572e3 |
IEDL.DBID | BENPR |
ISSN | 0002-9149 |
IngestDate | Sat Aug 17 00:05:19 EDT 2024 Thu Oct 10 22:08:11 EDT 2024 Thu Sep 26 18:32:55 EDT 2024 Sat Sep 28 07:59:09 EDT 2024 Fri Feb 23 02:27:32 EST 2024 Thu Aug 18 17:13:08 EDT 2022 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Language | English |
License | Copyright © 2015 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c448t-a50f15cd830e19b9110a8ee7acd8df4766b9542ea35be6846865c65c07f6572e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 26372212 |
PQID | 1722479748 |
PQPubID | 41200 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_1722928284 proquest_journals_1722479748 crossref_primary_10_1016_j_amjcard_2015_07_053 pubmed_primary_26372212 elsevier_sciencedirect_doi_10_1016_j_amjcard_2015_07_053 elsevier_clinicalkeyesjournals_1_s2_0_S0002914915017567 |
PublicationCentury | 2000 |
PublicationDate | 2015-11-01 |
PublicationDateYYYYMMDD | 2015-11-01 |
PublicationDate_xml | – month: 11 year: 2015 text: 2015-11-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: New York |
PublicationTitle | The American journal of cardiology |
PublicationTitleAlternate | Am J Cardiol |
PublicationYear | 2015 |
Publisher | Elsevier Inc Elsevier Limited |
Publisher_xml | – name: Elsevier Inc – name: Elsevier Limited |
References | Boullier, Bird, Chang, Dennis, Friedman, Gillotre-Taylor, Horkko, Palinski, Quehenberger, Shaw, Steinberg, Terpstra, Witztum (bib11) 2001; 947 Sobotka, Brottman, Weitz, Birnbaum, Skosey, Zarling (bib9) 1993; 14 Tsutsui, Tsutamoto, Wada, Maeda, Mabuchi, Hayashi, Ohnishi, Kinoshita (bib14) 2002; 39 Junqueira, Barros, Chan, Rodrigues, Giavarotti, Abud, Deucher (bib23) 2004; 25 Steinerova, Racek, Stozicky, Zima, Fialova, Lapin (bib15) 2001; 50 Griendling, FitzGerald (bib2) 2003; 108 Wright, Doughty, Pearl, Gamble, Whalley, Walsh, Gordon, Bagg, Oxenham, Yandle, Richards, Sharpe (bib25) 2003; 42 Willis, Salazar-Cantú, Silva-Platas, Fernández-Sada, Villegas, Rios-Argaiz, González-Serrano, Sánchez, Guerrero-Beltrán, García, Torre-Amione, García-Rivas, Altamirano (bib6) 2015; 308 Lehtimaki, Lehtinen, Solakivi, Nikkila, Jaakkola, Jokela, Yla-Herttuala, Luoma, Koivula, Nikkari (bib17) 1999; 19 Shimoni, Bar, Zilberman, George (bib18) 2014; 128 Anand, Fisher, Chiang, Latini, Masson, Maggioni, Glazer, Tognoni, Cohn (bib26) 2003; 107 Chen, Keaney (bib1) 2012; 14 Ellis, Anderson, Lang, Blackman, Morris, Morris-Thurgood, McDowell, Jackson, Lewis, Frenneaux (bib4) 2000; 36 Charach, George, Afek, Wexler, Sheps, Keren, Rubinstein (bib24) 2009; 15 George, Wexler, Roth, Barak, Sheps, Keren (bib21) 2006; 8 Holvoet, Vanhaecke, Janssens, Van de Werf, Collen (bib12) 1998; 98 Holvoet, Mertens, Verhamme, Bogaerts, Beyens, Verhaeghe, Collen, Muls, Van de Werf (bib13) 2001; 21 Salonen, Yla-Herttuala, Yamamoto, Butler, Korpela, Salonen, Nyyssonen, Palinski, Witztum (bib16) 1992; 339 Myers, McGuire, Liss, Ifrim, Grotzinger, Young (bib5) 1977; 197 Chang, Binder, Torzewski, Witztum (bib27) 2002; 99 Willis, Salazar-Cantú, Silva-Platas, Fernández-Sada, Villegas, Rios-Argaiz, González-Serrano, Sánchez, Guerrero-Beltrán, García, Torre-Amione, García-Rivas, Altamirano (bib7) 2015; 179 George, Harats, Bakshi, Adler, Levy, Gilburd, Shoenfeld (bib20) 1999; 68 Mallat, Philip, Lebret, Chatel, Maclouf, Tedgui (bib10) 1998; 97 Kistorp, Galatius, Gusstafsson, Faber, Corell, Hildebrandt (bib19) 2005; 100 Siveski-Iliskovic, Hill, Chow, Singal (bib8) 1995; 91 De La Fuente (bib22) 2002; 56 McMurray, Chopra, Abdullah, Smith, Dargie (bib3) 1993; 14 Chen (10.1016/j.amjcard.2015.07.053_bib1) 2012; 14 De La Fuente (10.1016/j.amjcard.2015.07.053_bib22) 2002; 56 George (10.1016/j.amjcard.2015.07.053_bib20) 1999; 68 George (10.1016/j.amjcard.2015.07.053_bib21) 2006; 8 Kistorp (10.1016/j.amjcard.2015.07.053_bib19) 2005; 100 Willis (10.1016/j.amjcard.2015.07.053_bib7) 2015; 179 McMurray (10.1016/j.amjcard.2015.07.053_bib3) 1993; 14 Siveski-Iliskovic (10.1016/j.amjcard.2015.07.053_bib8) 1995; 91 Holvoet (10.1016/j.amjcard.2015.07.053_bib13) 2001; 21 Ellis (10.1016/j.amjcard.2015.07.053_bib4) 2000; 36 Tsutsui (10.1016/j.amjcard.2015.07.053_bib14) 2002; 39 Mallat (10.1016/j.amjcard.2015.07.053_bib10) 1998; 97 Lehtimaki (10.1016/j.amjcard.2015.07.053_bib17) 1999; 19 Myers (10.1016/j.amjcard.2015.07.053_bib5) 1977; 197 Steinerova (10.1016/j.amjcard.2015.07.053_bib15) 2001; 50 Shimoni (10.1016/j.amjcard.2015.07.053_bib18) 2014; 128 Boullier (10.1016/j.amjcard.2015.07.053_bib11) 2001; 947 Salonen (10.1016/j.amjcard.2015.07.053_bib16) 1992; 339 Sobotka (10.1016/j.amjcard.2015.07.053_bib9) 1993; 14 Anand (10.1016/j.amjcard.2015.07.053_bib26) 2003; 107 Griendling (10.1016/j.amjcard.2015.07.053_bib2) 2003; 108 Chang (10.1016/j.amjcard.2015.07.053_bib27) 2002; 99 Willis (10.1016/j.amjcard.2015.07.053_bib6) 2015; 308 Holvoet (10.1016/j.amjcard.2015.07.053_bib12) 1998; 98 Junqueira (10.1016/j.amjcard.2015.07.053_bib23) 2004; 25 Charach (10.1016/j.amjcard.2015.07.053_bib24) 2009; 15 Wright (10.1016/j.amjcard.2015.07.053_bib25) 2003; 42 |
References_xml | – volume: 947 start-page: 214 year: 2001 end-page: 222 ident: bib11 article-title: Scavenger receptors, oxidized LDL, and atherosclerosis publication-title: Ann N Y Acad Sci contributor: fullname: Witztum – volume: 97 start-page: 1536 year: 1998 end-page: 1539 ident: bib10 article-title: Elevated levels of 8-iso-prostaglandin F publication-title: Circulation contributor: fullname: Tedgui – volume: 8 start-page: 58 year: 2006 end-page: 62 ident: bib21 article-title: Usefulness of anti-oxidized LDL antibody determination for assessment of clinical control in patients with heart failure publication-title: Eur J Heart Fail contributor: fullname: Keren – volume: 39 start-page: 957 year: 2002 end-page: 962 ident: bib14 article-title: Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure publication-title: J Am Coll Cardiol contributor: fullname: Kinoshita – volume: 339 start-page: 883 year: 1992 end-page: 887 ident: bib16 article-title: Autoantibodies against oxidized LDL and progression of carotid atherosclerosis publication-title: Lancet contributor: fullname: Witztum – volume: 42 start-page: 1793 year: 2003 end-page: 1800 ident: bib25 article-title: Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial publication-title: J Am Coll Cardiol contributor: fullname: Sharpe – volume: 308 start-page: H467 year: 2015 end-page: H477 ident: bib6 article-title: Impaired oxidative metabolism and calcium mishandling underlie cardiac dysfunction in a rat model of postacute isoproterenol-induced cardiomyopathy publication-title: Am J Physiol Heart Circ Physiol contributor: fullname: Altamirano – volume: 15 start-page: 770 year: 2009 end-page: 774 ident: bib24 article-title: Antibodies to oxidized LDL as predictors of morbidity and mortality in patients with chronic heart failure publication-title: J Card Fail contributor: fullname: Rubinstein – volume: 36 start-page: 1474 year: 2000 end-page: 1482 ident: bib4 article-title: Neutrophil superoxide anion- generating capacity, endothelial function and oxidative stress in chronic heart failure: effects of short and long-term vitamin C therapy publication-title: J Am Coll Cardiol contributor: fullname: Frenneaux – volume: 14 start-page: 1493 year: 1993 end-page: 1498 ident: bib3 article-title: Evidence of oxidative stress in chronic heart failure in humans publication-title: Eur Heart J contributor: fullname: Dargie – volume: 91 start-page: 10 year: 1995 end-page: 15 ident: bib8 article-title: Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect publication-title: Circulation contributor: fullname: Singal – volume: 107 start-page: 1278 year: 2003 end-page: 1283 ident: bib26 article-title: Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT) publication-title: Circulation contributor: fullname: Cohn – volume: 56 start-page: S5 year: 2002 end-page: S8 ident: bib22 article-title: Effects of antioxidants on immune system ageing publication-title: Eur J Clin Nutr contributor: fullname: De La Fuente – volume: 14 start-page: 476 year: 2012 end-page: 483 ident: bib1 article-title: Evolving concepts of oxidative stress and reactive oxygen species in cardiovascular disease publication-title: Curr Atheroscler Rep contributor: fullname: Keaney – volume: 197 start-page: 165 year: 1977 end-page: 167 ident: bib5 article-title: Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumour response publication-title: Science contributor: fullname: Young – volume: 108 start-page: 2034 year: 2003 end-page: 2040 ident: bib2 article-title: Oxidative stress and cardiovascular injury: Part II. Animal and human studies publication-title: Circulation contributor: fullname: FitzGerald – volume: 19 start-page: 23 year: 1999 end-page: 27 ident: bib17 article-title: Autoantibodies against low density lipoprotein in patients with angiographically verified coronary artery disease publication-title: Arterioscler Thromb Vasc Biol contributor: fullname: Nikkari – volume: 128 start-page: 54 year: 2014 end-page: 61 ident: bib18 article-title: Autoantibodies to oxidized low-density lipoprotein in patients with aortic regurgitation: association with aortic diameter size publication-title: Cardiology contributor: fullname: George – volume: 68 start-page: 263 year: 1999 end-page: 266 ident: bib20 article-title: Anti-oxidized low density lipoprotein antibody determination as a predictor of restenosis following percutaneous transluminal coronary angioplasty publication-title: Immunol Lett contributor: fullname: Shoenfeld – volume: 99 start-page: 13043 year: 2002 end-page: 13048 ident: bib27 article-title: C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphorylcholine of oxidized phospholipids publication-title: Proc Natl Acad Sci USA contributor: fullname: Witztum – volume: 25 start-page: 5 year: 2004 end-page: 16 ident: bib23 article-title: Aging and oxidative stress publication-title: Mol Aspects Med contributor: fullname: Deucher – volume: 21 start-page: 844 year: 2001 end-page: 848 ident: bib13 article-title: Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease publication-title: Arterioscler Thromb Vasc Biol contributor: fullname: Van de Werf – volume: 100 start-page: 281 year: 2005 end-page: 287 ident: bib19 article-title: Prevalence and characteristics of diabetic patients in chronic heart failure population publication-title: Int J Cardiol contributor: fullname: Hildebrandt – volume: 98 start-page: 1487 year: 1998 end-page: 1494 ident: bib12 article-title: Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease publication-title: Circulation contributor: fullname: Collen – volume: 179 start-page: 305 year: 2015 end-page: 308 ident: bib7 article-title: Reactive oxidative metabolites are associated with the severity of heart failure and predict future cardiovascular events in heart failure with preserved left ventricular ejection fraction publication-title: Int J Cardiol contributor: fullname: Altamirano – volume: 14 start-page: 643 year: 1993 end-page: 647 ident: bib9 article-title: Elevated breath pentane in heart failure reduced by free radical scavenge publication-title: Free Radic Biol Med contributor: fullname: Zarling – volume: 50 start-page: 131 year: 2001 end-page: 141 ident: bib15 article-title: Antibodies against oxidized LDL - theory and clinical use publication-title: Physiol Res contributor: fullname: Lapin – volume: 308 start-page: H467 year: 2015 ident: 10.1016/j.amjcard.2015.07.053_bib6 article-title: Impaired oxidative metabolism and calcium mishandling underlie cardiac dysfunction in a rat model of postacute isoproterenol-induced cardiomyopathy publication-title: Am J Physiol Heart Circ Physiol doi: 10.1152/ajpheart.00734.2013 contributor: fullname: Willis – volume: 179 start-page: 305 year: 2015 ident: 10.1016/j.amjcard.2015.07.053_bib7 article-title: Reactive oxidative metabolites are associated with the severity of heart failure and predict future cardiovascular events in heart failure with preserved left ventricular ejection fraction publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2014.11.018 contributor: fullname: Willis – volume: 15 start-page: 770 year: 2009 ident: 10.1016/j.amjcard.2015.07.053_bib24 article-title: Antibodies to oxidized LDL as predictors of morbidity and mortality in patients with chronic heart failure publication-title: J Card Fail doi: 10.1016/j.cardfail.2009.05.009 contributor: fullname: Charach – volume: 98 start-page: 1487 year: 1998 ident: 10.1016/j.amjcard.2015.07.053_bib12 article-title: Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease publication-title: Circulation doi: 10.1161/01.CIR.98.15.1487 contributor: fullname: Holvoet – volume: 339 start-page: 883 year: 1992 ident: 10.1016/j.amjcard.2015.07.053_bib16 article-title: Autoantibodies against oxidized LDL and progression of carotid atherosclerosis publication-title: Lancet doi: 10.1016/0140-6736(92)90926-T contributor: fullname: Salonen – volume: 25 start-page: 5 year: 2004 ident: 10.1016/j.amjcard.2015.07.053_bib23 article-title: Aging and oxidative stress publication-title: Mol Aspects Med doi: 10.1016/j.mam.2004.02.003 contributor: fullname: Junqueira – volume: 19 start-page: 23 year: 1999 ident: 10.1016/j.amjcard.2015.07.053_bib17 article-title: Autoantibodies against low density lipoprotein in patients with angiographically verified coronary artery disease publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.19.1.23 contributor: fullname: Lehtimaki – volume: 14 start-page: 476 year: 2012 ident: 10.1016/j.amjcard.2015.07.053_bib1 article-title: Evolving concepts of oxidative stress and reactive oxygen species in cardiovascular disease publication-title: Curr Atheroscler Rep doi: 10.1007/s11883-012-0266-8 contributor: fullname: Chen – volume: 42 start-page: 1793 year: 2003 ident: 10.1016/j.amjcard.2015.07.053_bib25 article-title: Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2003.05.011 contributor: fullname: Wright – volume: 108 start-page: 2034 year: 2003 ident: 10.1016/j.amjcard.2015.07.053_bib2 article-title: Oxidative stress and cardiovascular injury: Part II. Animal and human studies publication-title: Circulation doi: 10.1161/01.CIR.0000093661.90582.c4 contributor: fullname: Griendling – volume: 50 start-page: 131 year: 2001 ident: 10.1016/j.amjcard.2015.07.053_bib15 article-title: Antibodies against oxidized LDL - theory and clinical use publication-title: Physiol Res contributor: fullname: Steinerova – volume: 91 start-page: 10 year: 1995 ident: 10.1016/j.amjcard.2015.07.053_bib8 article-title: Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect publication-title: Circulation doi: 10.1161/01.CIR.91.1.10 contributor: fullname: Siveski-Iliskovic – volume: 128 start-page: 54 year: 2014 ident: 10.1016/j.amjcard.2015.07.053_bib18 article-title: Autoantibodies to oxidized low-density lipoprotein in patients with aortic regurgitation: association with aortic diameter size publication-title: Cardiology doi: 10.1159/000357835 contributor: fullname: Shimoni – volume: 100 start-page: 281 year: 2005 ident: 10.1016/j.amjcard.2015.07.053_bib19 article-title: Prevalence and characteristics of diabetic patients in chronic heart failure population publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2004.10.024 contributor: fullname: Kistorp – volume: 21 start-page: 844 year: 2001 ident: 10.1016/j.amjcard.2015.07.053_bib13 article-title: Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.21.5.844 contributor: fullname: Holvoet – volume: 197 start-page: 165 year: 1977 ident: 10.1016/j.amjcard.2015.07.053_bib5 article-title: Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumour response publication-title: Science doi: 10.1126/science.877547 contributor: fullname: Myers – volume: 39 start-page: 957 year: 2002 ident: 10.1016/j.amjcard.2015.07.053_bib14 article-title: Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure publication-title: J Am Coll Cardiol doi: 10.1016/S0735-1097(02)01721-7 contributor: fullname: Tsutsui – volume: 14 start-page: 1493 year: 1993 ident: 10.1016/j.amjcard.2015.07.053_bib3 article-title: Evidence of oxidative stress in chronic heart failure in humans publication-title: Eur Heart J doi: 10.1093/eurheartj/14.11.1493 contributor: fullname: McMurray – volume: 947 start-page: 214 year: 2001 ident: 10.1016/j.amjcard.2015.07.053_bib11 article-title: Scavenger receptors, oxidized LDL, and atherosclerosis publication-title: Ann N Y Acad Sci doi: 10.1111/j.1749-6632.2001.tb03943.x contributor: fullname: Boullier – volume: 68 start-page: 263 year: 1999 ident: 10.1016/j.amjcard.2015.07.053_bib20 article-title: Anti-oxidized low density lipoprotein antibody determination as a predictor of restenosis following percutaneous transluminal coronary angioplasty publication-title: Immunol Lett doi: 10.1016/S0165-2478(99)00050-4 contributor: fullname: George – volume: 107 start-page: 1278 year: 2003 ident: 10.1016/j.amjcard.2015.07.053_bib26 article-title: Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT) publication-title: Circulation doi: 10.1161/01.CIR.0000054164.99881.00 contributor: fullname: Anand – volume: 97 start-page: 1536 year: 1998 ident: 10.1016/j.amjcard.2015.07.053_bib10 article-title: Elevated levels of 8-iso-prostaglandin F2 alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure publication-title: Circulation doi: 10.1161/01.CIR.97.16.1536 contributor: fullname: Mallat – volume: 56 start-page: S5 year: 2002 ident: 10.1016/j.amjcard.2015.07.053_bib22 article-title: Effects of antioxidants on immune system ageing publication-title: Eur J Clin Nutr doi: 10.1038/sj.ejcn.1601476 contributor: fullname: De La Fuente – volume: 99 start-page: 13043 year: 2002 ident: 10.1016/j.amjcard.2015.07.053_bib27 article-title: C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphorylcholine of oxidized phospholipids publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.192399699 contributor: fullname: Chang – volume: 8 start-page: 58 year: 2006 ident: 10.1016/j.amjcard.2015.07.053_bib21 article-title: Usefulness of anti-oxidized LDL antibody determination for assessment of clinical control in patients with heart failure publication-title: Eur J Heart Fail doi: 10.1016/j.ejheart.2005.04.015 contributor: fullname: George – volume: 36 start-page: 1474 year: 2000 ident: 10.1016/j.amjcard.2015.07.053_bib4 article-title: Neutrophil superoxide anion- generating capacity, endothelial function and oxidative stress in chronic heart failure: effects of short and long-term vitamin C therapy publication-title: J Am Coll Cardiol doi: 10.1016/S0735-1097(00)00916-5 contributor: fullname: Ellis – volume: 14 start-page: 643 year: 1993 ident: 10.1016/j.amjcard.2015.07.053_bib9 article-title: Elevated breath pentane in heart failure reduced by free radical scavenge publication-title: Free Radic Biol Med doi: 10.1016/0891-5849(93)90145-K contributor: fullname: Sobotka |
SSID | ssj0001156 |
Score | 2.254949 |
Snippet | Elevated level of antibodies to oxidized low-density lipoproteins (OxLDL-Ab) was shown to reliably predict morbidity and mortality in patients with heart... |
SourceID | proquest crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1379 |
SubjectTerms | Academic Medical Centers Aged Aged, 80 and over Antibodies - blood Atherosclerosis Biomarkers - blood Blood platelets Cardiovascular Chronic Disease Family medical history Female Follow-Up Studies Free radicals Glucose Heart attacks Heart failure Heart Failure - diagnosis Heart Failure - epidemiology Heart Failure - mortality Hospitalization Hospitalization - statistics & numerical data Humans Immunoglobulins Israel - epidemiology Laboratories Lipoproteins, LDL - blood Low density lipoprotein Male Medical records Morbidity Mortality Oxidative stress Peptides Phosphatase Predictive Value of Tests Prognosis Proteins Retrospective Studies Sensitivity and Specificity Severity of Illness Index Survival Rate Variables |
SummonAdditionalLinks | – databaseName: Elsevier ScienceDirect Freedom Collection dbid: AIKHN link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwEB6VrYS4oPIfWpCRuKbrTeI4Oa4KqwW6pQdWKifLScbIK0hWm6xaeINe-wRceBEehSdhvEm2QqhCQsol8W88nplv5JkxwEupJc8lMVKeIBkopkj9LErR51xnGIcyCzYH7bOTeDqP3p6Jsx046mNhnFtlJ_tbmb6R1t2XYbeaw6W1LsaXBykBfII0pANjeQt2SR1F0QB2x2_eTU-2AplAT9yjYNfgOpBnuDjUXxY50cI5eYk2jWd4k4q6CYJuVNFkD-52GJKN22negx0s78PtWXdK_gCu5jWa9WcnxFhl2LhsbFY5b0HWVOz9hS3sNyzYcXXuv3Lu681XdmyX1SZjgy1rpmt2unKduYt4XAezapVRI6qny4LKKuecZ2tmSzYlRmnYRFvn3c5O2yStNRt_ogF-Xf6Ixc_vH6lK_RDmk9cfjqZ-d_eCn5PB1vhacDNyiQNCjqM0I5HIdYIoNX0qTCTjOEtFFKAOBdGUQEwSi5weLk0sZIDhIxiUVYlPgJH9LYw0KSYGo0QnSU42JZocRWgik-UeHPbLrZZtig3V-54tVEcf5eijuFREHw9kTxTVx4-SxMO6Y79ajVQdKK7-2iIeJNuWf-wyRQrkX4Me9ORX1-NIQkCSTLLEgxfbYmJQd-qiS6zWbZ3UGbaRB4_bbbP9zYC4ISDw8PT_57UPd9xbGx55AINmtcZnhJOa7HnHB78BKAwThw priority: 102 providerName: Elsevier |
Title | Usefulness of Antibodies to Oxidized Low-Density Lipoproteins as Predictors of Morbidity and Prognosis in Heart Failure Patients Aged ≥65 Years |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0002914915017567 https://dx.doi.org/10.1016/j.amjcard.2015.07.053 https://www.ncbi.nlm.nih.gov/pubmed/26372212 https://www.proquest.com/docview/1722479748 https://search.proquest.com/docview/1722928284 |
Volume | 116 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lj9MwELbYrYS4IN4ElspIXNPNy3FyAFRgqwLbUgGVyslyEhulgrjUqXgc-BX8YGYap3takKIcEsdO8nnG33jGY0KecMmDkoMglZkCA0VXuV8kufKDQBYqjXkR7R3ts3k6XSZvVmzlJtysC6vsdeJeUVemxDnyUxhoo4QD-82eb775uGsUelfdFhpHZBCFCbppBy_O5ov3B10MfCftCXAOxsDFGp7T9Uh-XZcAA8Z3sS6DZ3zZ6HQZ-9yPQpMb5Lqjj3Tc4X2TXFHNLXJ15hzkt8mfpVV69wX1FzWajpu2LgwGCtLW0Hc_6qr-pSp6br77rzByvf1Jz-uN2SdrqBtLpaWLLVaGe_BgBTOzLeAhKCebCu4ZjMurLa0bOgUZaelE1hjYThddflZLx5-hgWfUbOnTlNFPUMjeIcvJ2ceXU99tvOCXYK21vmSBDjFrQByoMC9AHwYyU4pLuFTphKdpkbMkUjJmACgwmCxlJRwB1ynjkYrvkuPGNOo-oWB8M811rjKtkkxmWQkGpdKlYrFOdFF6ZNT_cLHp8muIPvBsLRxCAhESAReAkEd4D4voF4-CulPWyZ4VobCRCMQHBB0xB8oLHCnlHskOTzp60dEGAaPH_xo96TuAuGjn0CM98vhwG6QTXS6yUWbXlcnRqk08cq_rOIfPjEAUImAOD_5d-UNyDd-kW_94Qo7b7U49AiLUFkNyNPodwpmv-JAMxq_fTudDJwF_AUofC2I |
link.rule.ids | 315,786,790,4521,12083,21416,24144,27955,27956,31752,31753,33777,33778,43343,43838,45618,45712,74100,74657 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lj9MwELagKwEXxJvCAkbimt00iWPnAKjAVgXaUsFWWk6Wk9goFcSlTsXjd_CDmWmc7GlByinxI8nnGX_jGY8JecYVDwsOglQIDQaKKbMgTzIdhKHKdRrzPNo72ueLdLpK3p2xM7_g5nxYZacT94q6tAWukR_DRBslHNiveLn5HuCpUehd9UdoXCYHmHJTDMjBq5PF8mOvi4HvpB0BzsAYON_Dc7w-Ut_WBcCA8V2szeAZXzQ7XcQ-97PQ5Aa57ukjHbd43ySXdH2LXJl7B_lt8mfltNl9Rf1FraHjuqlyi4GCtLH0w8-qrH7rks7sj-ANRq43v-is2th9soaqdlQ5utxiY3gGDzYwt9scKkE5VZfwzGJcXuVoVdMpyEhDJ6rCwHa6bPOzOjr-Ah28oHZLn6eMfoZC7g5ZTU5OX08Df_BCUIC11gSKhWaEWQPiUI-yHPRhqITWXMGt0iQ8TfOMJZFWMQNAgcGIlBVwhdykjEc6vksGta31fULB-GaGm0wLoxOhhCjAoNSm0Cw2icmLITnqfrjctPk1ZBd4tpYeIYkIyZBLQGhIeAeL7DaPgrrTzsuekyPpIhnKTwg6Yg6UFzhSyodE9DU9vWhpg4TZ43-dHnYDQJ7304_IIXnaPwbpRJeLqrXdtWUytGqTIbnXDpz-MyMQhQiYw4N_N_6EXJ2ezmdy9nbx_iG5hm_V7oU8JINmu9OPgBQ1-WM_8v8CM8QK5Q |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lj9MwELZgkVZcEO8Nu4CRuGbrJnGcHABVLFWBdqkElcrJchIbpRJxt86Kx-_gBzOTON3TgtRT49hJ5_VN_XmGkJdCCVYKMKQy05CgmCoPiyTXIWOq0GksiqjbaF-cp7NV8mHN157_5DytcvCJnaOubIn_kY8g0EaJAPSbjYynRSzPpm-2FyF2kMKdVt9O4ya5BVGSYRsHsd4nX4h80gEK55AWXJ3mGW1O1fdNCQJBphfva3nG18Wp63BoF4-md8kdDyTppJf8PXJDN_fJ4cJvlT8gf1ZOwyugJ6PW0EnT1oVFyiBtLf30s67q37qic_sjPEMOe_uLzuut7co21I2jytHlDifDbjw4wcLuCrgJxqmmgmsWGXq1o3VDZ2AtLZ2qGinudNlXanV08g0WeE3tjr5KOf0Kg9xDspq--_J2FvoWDGEJeVsbKs7MGOsHxEyP8wI8I1OZ1kLBV5VJRJoWOU8irWIOogUsk6W8hA8TJuUi0vEjctDYRh8RCmk4N8LkOjM6yVSWlZBaalNqHpvEFGVATocfXG77ShtyoKBtpJeQRAlJJiRIKCBiEIscjpGC49POW6GTY-kiyeRnFDrKHMAvoKVUBCTb3-mBRg8gJMSR_y16MiiAvFpnr5sBebG_DHaKmy-q0fayH5NjfpsE5HGvOPvXjMAoIsAQT_49-XNyCCov5-_PPx6T2_hQ_aHIE3LQ7i71U0BHbfGsU_u_BXANog |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Usefulness+of+Antibodies+to+Oxidized+Low-Density+Lipoproteins+as+Predictors+of+Morbidity+and+Prognosis+in+Heart+Failure+Patients+Aged+%E2%89%A565%C2%A0Years&rft.jtitle=The+American+journal+of+cardiology&rft.au=Charach%2C+Gideon%2C+MD&rft.au=Michowitz%2C+Yoav%2C+MD&rft.au=Rogowski%2C+Ori%2C+MD&rft.au=Charach%2C+Lior%2C+BA&rft.date=2015-11-01&rft.issn=0002-9149&rft.eissn=1879-1913&rft.volume=116&rft.issue=9&rft.spage=1379&rft.epage=1384&rft_id=info:doi/10.1016%2Fj.amjcard.2015.07.053&rft.externalDocID=1_s2_0_S0002914915017567 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00029149%2FS0002914914X00445%2Fcov150h.gif |